| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2139591 | Leukemia Research | 2007 | 6 Pages |
Abstract
Our results suggest that MPA may be recommended as an additional component of lymphoma chemotherapeutical regimens, with special considerations to post-transplant lymphomas.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Gyula VégsÅ, Anna Sebestyén, Sándor Paku, Gábor Barna, Melinda Hajdu, Mária Tóth, JenÅ Járay, László Kopper,